News
-
-
PRESS RELEASE
SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
SCHOTT Pharma's preliminary results for fiscal year 2025 show revenue growth and increased EBITDA margin. Outlook for FY 2026 includes moderate revenue growth and mid-term guidance updates towards 30% EBITDA margin by 2029 -
-
PRESS RELEASE
Start-up of the first deep well dedicated to Natural Hydrogen EUR 8.8m in funding grants secured for the project
Start-up of the first deep well dedicated to Natural Hydrogen by FDE in Moselle, France, under REGALOR II program supported by Grand Est Region and EU, securing €8.8m grants -
-
-
-
-
PRESS RELEASE
Omer-Decugis and Cie strengthens its presence in West Africa with the acquisition of the Ivorian mango export company, Vergers du Bandama
Omer-Decugis & Cie acquires Ivorian company Vergers du Bandama, reinforcing its position in African mango market. Acquisition aligned with upstream value chain strategy -